Afatinib Tablets

Name: Afatinib Tablets
Brand: Artemisine Medicines Technology Co., Ltd.

Tablets

Afatinib Tablets — GMP manufactured tablets by Artemisine Medicines Technology. Original manufacturer supply with stable quality, factory direct price and full batch documentation for global markets.

Product Name	Afatinib Tablets
Dosage Form	Tablets
Strength	40 mg
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Tablets

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

Selected solid tumours and haematological malignancies (renal cell carcinoma, NSCLC with activating EGFR mutations, gastrointestinal stromal tumours) — use according to molecular testing and oncology protocol.

💧Administration▾

Oral once daily with or without food (follow the specific product's instructions); pemetrexed is given as an intravenous infusion with folate and vitamin B12 supplementation. Swallow tablets whole.

⚖️Dosage▾

Dose is indication-specific and administered under oncologist supervision, e.g. gefitinib 250 mg once daily; erlotinib 150 mg once daily; imatinib 400 mg once daily; afatinib 40 mg once daily; pemetrexed 500 mg/m² every 3 weeks. Dose reduction is required for toxicity.

⚠️Precautions & Warnings▾

Significant toxicity: rash, diarrhoea, hepatic enzyme elevation, interstitial lung disease and QT prolongation; teratogenic — effective contraception required. Monitor blood counts, liver and kidney function, and electrolytes regularly; target-therapy must not be self-managed.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Afatinib Tablets — Frequently Asked Questions

Which documents are provided for Afatinib Tablets registration?

Every batch of Afatinib Tablets ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Afatinib Tablets?

MOQ and lead time for Afatinib Tablets depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Afatinib Tablets, subject to the regulatory requirements of the destination market.

Which markets have you exported tablets products to?

We have supplied tablets products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Afatinib Tablets controlled?

Afatinib Tablets is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›